Low-Contrast Visual Tests Reveal Better Alemtuzumab EfficacyLow-Contrast Visual Tests Reveal Better Alemtuzumab Efficacy

Standard visual acuity testing misses some visual dysfunction in patients with MS. Sloan low-contrast acuity testing revealed superior efficacy for alemtuzumab over interferon beta-1a in CARE-MS I. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news